Literature DB >> 9521148

Apoptosis in cord blood T lymphocytes from infants of human immunodeficiency virus-infected mothers.

A Economides1, I Schmid, D J Anisman-Posner, S Plaeger, Y J Bryson, C H Uittenbogaart.   

Abstract

Apoptosis continues to be controversial in human immunodeficiency virus (HIV)-induced pathogenesis. To investigate whether apoptosis occurs with HIV exposure with or without subsequent infection, levels of apoptosis were measured in cord blood lymphocytes (CBL) from seven newborns delivered to HIV-infected mothers and seven normal, unexposed newborns. Live cells were costained with antibodies to cell surface markers and the DNA dye 7-amino actinomycin D to immunophenotype apoptotic CBL subsets. Apoptosis was measured in fresh and cultured CBL in the presence and absence of CD3 T-cell receptor stimulation. Compared to the CD4+ CBL from HIV-unexposed newborns, CD4+ CBL from six HIV-exposed, noninfected newborns demonstrated significantly greater apoptosis after overnight culture even in the absence of CD3 stimulation. Compared to HIV-unexposed controls, CD8+ CBL from the six HIV-exposed newborns also demonstrated increased levels of apoptosis after overnight culture without stimulation. The one HIV-infected newborn in this study showed the highest levels of CD4+ and CD8+ apoptotic CBL. The data suggest that levels of apoptosis are increased in infants in association with HIV infection. Furthermore, CD4+ and CD8+ cord blood lymphocytes from HIV-exposed infants behaved differently than T lymphocytes from either normal, unexposed infants or an HIV-infected infant. These results suggest that exposure to HIV or HIV-induced factors increases the levels of apoptosis in CBL.

Entities:  

Mesh:

Year:  1998        PMID: 9521148      PMCID: PMC121363          DOI: 10.1128/CDLI.5.2.230-234.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  10 in total

1.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children.

Authors:  K M Debatin; A Fahrig-Faissner; S Enenkel-Stoodt; W Kreuz; A Benner; P H Krammer
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

3.  Clearance of HIV infection in a perinatally infected infant.

Authors:  Y J Bryson; S Pang; L S Wei; R Dickover; A Diagne; I S Chen
Journal:  N Engl J Med       Date:  1995-03-30       Impact factor: 91.245

4.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.

Authors:  W Emlen; J Niebur; R Kadera
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

5.  A rapid method for measuring apoptosis and dual-color immunofluorescence by single laser flow cytometry.

Authors:  I Schmid; C H Uittenbogaart; B Keld; J V Giorgi
Journal:  J Immunol Methods       Date:  1994-04-15       Impact factor: 2.303

6.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors:  E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal:  N Engl J Med       Date:  1994-11-03       Impact factor: 91.245

7.  Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes.

Authors:  T H Finkel; G Tudor-Williams; N K Banda; M F Cotton; T Curiel; C Monks; T W Baba; R M Ruprecht; A Kupfer
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

8.  Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.

Authors:  C A Muro-Cacho; G Pantaleo; A S Fauci
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

9.  T-cell death by apoptosis in vertically human immunodeficiency virus-infected children coincides with expansion of CD8+/interleukin-2 receptor-/HLA-DR+ T cells: sign of a possible role for herpes viruses as cofactors?

Authors:  R P Lauener; S Hüttner; M Buisson; J P Hossle; M Albisetti; J M Seigneurin; R A Seger; D Nadal
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

10.  Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression.

Authors:  M L Gougeon; H Lecoeur; A Dulioust; M G Enouf; M Crouvoiser; C Goujard; T Debord; L Montagnier
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

  10 in total
  13 in total

1.  Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents.

Authors:  Maristela Miyamoto; Silvana D Pessoa; Erika Ono; Daisy M Machado; Reinaldo Salomão; Regina C de M Succi; Savita Pahwa; Maria Isabel de Moraes-Pinto
Journal:  J Trop Pediatr       Date:  2010-04-13       Impact factor: 1.165

2.  In vivo effects of HIV-1 exposure in the presence and absence of single-dose nevirapine on cellular plasma activation markers of infants born to HIV-1-seropositive mothers.

Authors:  Diana B Schramm; Louise Kuhn; Glenda E Gray; Caroline T Tiemessen
Journal:  J Acquir Immune Defic Syndr       Date:  2006-08-15       Impact factor: 3.731

3.  The Nef-mediated AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with increased Fas/FasL expression on T cells and T-cell death but is not prevented in Fas-, FasL-, tumor necrosis factor receptor 1-, or interleukin-1beta-converting enzyme-deficient or Bcl2-expressing transgenic mice.

Authors:  Elena Priceputu; Isabelle Rodrigue; Pavel Chrobak; Johanne Poudrier; Tak W Mak; Zaher Hanna; Chunyan Hu; Denis G Kay; Paul Jolicoeur
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 4.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

5.  HIV-exposed-uninfected infants have increased inflammation and monocyte activation.

Authors:  Sahera Dirajlal-Fargo; Marisa M Mussi-Pinhata; Adriana Weinberg; Qilu Yu; Rachel Cohen; D Robert Harris; Emily Bowman; Janelle Gabriel; Manjusha Kulkarni; Nicholas Funderburg; Nahida Chakhtoura; Grace A McComsey
Journal:  AIDS       Date:  2019-04-01       Impact factor: 4.177

Review 6.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life.

Authors:  Jennifer A Slyker; Barbara Lohman-Payne; Grace C John-Stewart; Tao Dong; Dorothy Mbori-Ngacha; Kenneth Tapia; Ann Atzberger; Stephen Taylor; Sarah L Rowland-Jones; Catherine A Blish
Journal:  Front Immunol       Date:  2012-12-31       Impact factor: 7.561

8.  Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV.

Authors:  Florence M Momplaisir; Kathleen A Brady; Thomas Fekete; Dana R Thompson; Ana Diez Roux; Baligh R Yehia
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

9.  The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Guérin vaccination.

Authors:  Christine E Jones; Anneke C Hesseling; Nontobeko G Tena-Coki; Thomas J Scriba; Novel N Chegou; Martin Kidd; Robert J Wilkinson; Beate Kampmann
Journal:  AIDS       Date:  2015-01-14       Impact factor: 4.177

10.  Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency.

Authors:  Fatima Kakkar; Valerie Lamarre; Thierry Ducruet; Marc Boucher; Silvie Valois; Hugo Soudeyns; Normand Lapointe
Journal:  BMC Infect Dis       Date:  2014-05-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.